Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: Time to reconsider immunosuppression regimens?

Liver Transplantation

Volumn 17, Issue 11, 2011, Pages 1292-1298

  Houlihan, Diarmaid D ^a,b,c   Armstrong, Matthew J ^a,b,c   Davidov, Yana ^a,c,d   Hodson, James ^b   Nightingale, Peter ^b   Rowe, Ian A ^a,c   Paris, Sue ^a,c   Gunson, Bridget K ^a,c   Bramhall, Simon B ^a,c   Mutimer, David J ^a,c   Neuberger, James M ^a,c   Newsome, Philip N ^a,c  

^a University of Birmingham   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY INJURY; LIVER CELL CARCINOMA; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK FACTOR; TRANSPLANTATION; UNITED KINGDOM;

ACUTE KIDNEY INJURY; ADULT; AGED; COHORT STUDIES; FATTY LIVER; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES;

EID: 82955165643     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22382     Document Type: Article

References (29)

1. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-1350.
2. Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007;30:2119-2121. (Pubitemid 47219432)
3. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005;54:3541-3546. (Pubitemid 43334347)
4. Haring R, Wallaschofski H, Nauck M, Dörr M, Baumeister SE, Völzke H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepato-logy 2009;50:1403-1411.
5. Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, Muggeo M. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 2008;51:444-450.
6. Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia 2010;53:1341-1348.
7. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-940. (Pubitemid 37064766)
8. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calci-neurin-based immunotherapy: risk of development and treatment. Transplantation 2001;72:1934-1939. (Pubitemid 34027867)
9. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003;9:741-747. (Pubitemid 36874464)
10. Reich DJ, Clavien PA, Hodge EE; for MMF Renal Dysfunction After Liver Transplantation Working Group. Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results. Transplantation 2005;80:18-25. (Pubitemid 40980890)
11. Fairbanks KD, Eustace JA, Fine D, Thuluvath PJ. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Liver Transpl 2003;9:1079-1085. (Pubitemid 37304464)
12. Schnitzbauer AA, Doenecke A, Sothmann JL, Loss M, Farkas SA, Hartl J, et al. Improved outcome after 'bottom-up' immunosuppression in liver transplant recipients with preoperative renal impairment. Eur Surg Res 2010;45:356-367.
13. Neuberger JM, Mamelok RD, Neuhaus P, Pirenne J, Samuel D, Isoniemi H, et al.; for ReSpECT Study Group. Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant 2009;9:327-336.
14. Hübscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006;49:450-465. (Pubitemid 44631618)
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al.; for American Heart Association and National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
16. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-2483. (Pubitemid 43855050)
17. Chen J, Singhapricha T, Hu KQ, Hong JC, Steadman RH, Busuttil RW, Xia VW. Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: a matched study. Transplantation 2011;91: 348-353.
18. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; for Acute Dialysis Quality Initiative Workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 2004; 8:R204-R212.
19. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(suppl 1):S1-S266.
20. Campbell MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD, et al. Renal function after ortho-topic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005;11:1048-1055. (Pubitemid 41341753)
21. Hwang ST, Cho YK, Yun JW, Park JH, Kim HJ, Park DI, et al. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. Intern Med J 2010;40:437-442.
22. Targher G, Chonchol M, Zoppini G, Abaterusso C, Bonora E. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol 2011;54:1020-1029.
23. Schmitz V, Laudi S, Moeckel F, Puhl G, Stockmann M, Tran ZV, et al. Chronic renal dysfunction following liver transplantation. Clin Transplant 2008;22:333-340. (Pubitemid 351689664)
24. O'Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant 2006;21:2630-2636. (Pubitemid 44644543)
25. Charlton MR, Wall WJ, Ojo AO, Ginès P, Textor S, Shi-hab FS, et al.; for International Liver Transplantation Society Expert Panel. Report of the first International Liver Transplantation Society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl 2009;15:S1-S34.
26. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17: 2034-2047. (Pubitemid 44036188)
27. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neu-berger JM. Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation 1998;66:59-66. (Pubitemid 28341169)
28. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005;16: 763-773. (Pubitemid 41725113)
29. Maheshwari A, Yoo HY, Thuluvath PJ. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol 2004;99:538-542. (Pubitemid 38524137)